Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02409017 · ClinicalTrials.gov registry record · NA
A Comparison of Insulin Drip Protocols in Labor: A Randomized Trial
A NA study, sponsored by WellSpan Health.
- Terminated
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT02409017: Clinical Trial NA study, sponsored by WellSpan Health.
NCT02409017 is a NA study that was terminated before completion, run by WellSpan Health. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02409017, a NA study, was terminated before completion, sponsored by WellSpan Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
To assess which of two commonly utilized insulin drip protocols has better outcomes when used during the labor process.
Interventions
- PROCEDURE Insulin drip
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2015-04 |
| Est. Completion | 2016-07 |
| Phase | NA |
Why NCT02409017 stopped before completion
NCT02409017 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Insulin drip is the first listed.
NCT02409017 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02409017 about?
NCT02409017 is a clinical study titled "A Comparison of Insulin Drip Protocols in Labor: A Randomized Trial". To assess which of two commonly utilized insulin drip protocols has better outcomes when used during the labor process.
What is the current status of trial NCT02409017?
This trial is currently terminated. It is a NA study. The enrollment target is 20 participants. The study started on 2015-04. Estimated completion is 2016-07.
What interventions are being tested in trial NCT02409017?
The interventions under investigation include: Insulin drip (PROCEDURE).
Who is sponsoring clinical trial NCT02409017?
This trial is sponsored by WellSpan Health, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02409017's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia